MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET 2021-2028
MARKET OUTLOOK
Triton’s research report alludes that the Middle East and Africa’s clinical trial management market is calculated to surge at a CAGR of 9.55% during the estimated years 2021-2028. Turkey, South Africa, Saudi Arabia, the UAE, and Rest of Middle East & Africa shape the market in this region.
In the region, Turkey presents significant growth opportunities for pharmaceutical companies, owing to the large geriatric population and high occurrence of non-communicable diseases. Moreover, the country has a robust domestic production capacity, along with a well-developed network of skilled workforce, which adds to the studied market’s growth. Above all, international investment continues to increase in the country, driving the clinical trial management market on a growth path.
Similarly, Saudi Arabia offers a lucrative market for multinational companies in the region. The country’s diversification plans bode well for regional companies, with Vision 2030 stimulating the expansion of manufacturing agreements. Additionally, the growing demand for generic treatments is likely to help local players to increase their operations to satisfy these demands. Besides, the increase in government investments in the local drug industry and expansion of healthcare infrastructure are another set of factors that are likely to stimulate the demand for clinical trial management. Hence, as mentioned above, these factors are evaluated to expand the growth of the clinical trial management market across Saudi Arabia.
COMPETITIVE OUTLOOK
The companies thriving in the clinical trial management market are Oracle Corporation, Bio-Optronics Inc, Bioclinica Inc, Parexel International Corporation, and Arisglobal LLC.
- 1. MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET - SUMMARY
- 2. INDUSTRY OUTLOOK
- 2.1. MARKET SCOPE
- 2.2. KEY INSIGHTS
- 2.2.1. ENTERPRISE-BASED CTM CONTRIBUTES A MAJOR SHARE IN PRODUCT TYPE SEGMENT
- 2.2.2. HEALTHCARE PROVIDERS ARE RAPIDLY GROWING END-USERS IN THE MARKET
- 2.2.3. SOFTWARE IS THE LARGEST COMPONENT IN THE CLINICAL TRIAL MANAGEMENT MARKET
- 2.2.4. CLOUD MODEL OF DEPLOYMENT IS A PROMISING SEGMENT IN THE MARKET
- 2.3. PORTER’S FIVE FORCES ANALYSIS
- 2.3.1. THREAT OF NEW ENTRANTS
- 2.3.2. THREAT OF SUBSTITUTE
- 2.3.3. BARGAINING POWER OF SUPPLIERS
- 2.3.4. BARGAINING POWER OF BUYERS
- 2.3.5. INTENSITY OF COMPETITIVE RIVALRY
- 2.4. MARKET ATTRACTIVENESS INDEX
- 2.5. VENDOR SCORECARD
- 2.6. MARKET DRIVERS
- 2.6.1. ALARMING RISE IN CHRONIC DISEASES
- 2.6.2. SURGE IN RESEARCH & DEVELOPMENT IN THE MEDICAL SECTOR
- 2.6.3. BENEFITS OFFERED BY CTM SOFTWARE
- 2.7. MARKET RESTRAINTS
- 2.7.1. CONCERN REGARDING THE SECURITY OF CTM SYSTEMS
- 2.7.2. LACK OF SKILLED WORKFORCE
- 2.7.3. HIGH COST OF IMPLEMENTATION
- 2.8. MARKET OPPORTUNITIES
- 2.8.1. GROWTH IN CLINICAL TRIALS
- 2.8.2. OUTSOURCING CLINICAL TRIALS FOR COST REDUCTION
- 2.9. KEY STRATEGIC DEVELOPMENTS
- 2.9.1. MERGER & ACQUISITIONS
- 2.9.2. PRODUCT LAUNCH & DEVELOPMENTS
- 2.9.3. PARTNERSHIP, CONTRACT/AGREEMENT, & COLLABORATION
- 2.10. IMPACT OF COVID-19 ON THE CLINICAL TRIAL MANAGEMENT MARKET
- 3. MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY DEPLOYMENT MODE
- 3.1. WEB-BASED DEPLOYMENT
- 3.2. ON-PREMISE DEPLOYMENT
- 3.3. CLOUD-BASED DEPLOYMENT
- 4. MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY COMPONENT
- 4.1. SOFTWARE
- 4.2. HARDWARE
- 4.3. SERVICES
- 5. MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY PRODUCT TYPE
- 5.1. ENTERPRISE-BASED CTM
- 5.2. SITE-BASED CTM
- 6. MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY END-USER
- 6.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
- 6.2. CLINICAL RESEARCH ORGANIZATIONS
- 6.3. HEALTHCARE PROVIDERS
- 7. CLINICAL TRIAL MANAGEMENT MARKET – MIDDLE EAST AND AFRICA
- 7.1. UNITED ARAB EMIRATES
- 7.2. TURKEY
- 7.3. SAUDI ARABIA
- 7.4. SOUTH AFRICA
- 7.5. REST OF MIDDLE EAST & AFRICA
- 8. COMPETITIVE LANDSCAPE
- 8.1. MEDIDATA SOLUTIONS INC
- 8.2. ARISGLOBAL LLC
- 8.3. BIOCLINICA INC
- 8.4. BIO-OPTRONICS INC
- 8.5. ADVARRA (FORTE RESEARCH SYSTEMS INC)
- 8.6. ORACLE CORPORATION
- 8.7. IBM CORPORATION
- 8.8. MEDNET SOLUTIONS INC
- 8.9. PAREXEL INTERNATIONAL CORPORATION
- 8.10. VEEVA SYSTEMS INC
- 9. RESEARCH METHODOLOGY & SCOPE
- 9.1. RESEARCH SCOPE & DELIVERABLES
- 9.1.1. OBJECTIVES OF STUDY
- 9.1.2. SCOPE OF STUDY
- 9.2. SOURCES OF DATA
- 9.2.1. PRIMARY DATA SOURCES
- 9.2.2. SECONDARY DATA SOURCES
- 9.3. RESEARCH METHODOLOGY
- 9.3.1. EVALUATION OF PROPOSED MARKET
- 9.3.2. IDENTIFICATION OF DATA SOURCES
- 9.3.3. ASSESSMENT OF MARKET DETERMINANTS
- 9.3.4. DATA COLLECTION
- 9.3.5. DATA VALIDATION & ANALYSIS
- LIST OF TABLES
- TABLE 1: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
- TABLE 2: VENDOR SCORECARD
- TABLE 3: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2021-2028 (IN $ MILLION)
- TABLE 4: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
- TABLE 5: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2028 (IN $ MILLION)
- TABLE 6: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY END USER, 2021-2028 (IN $ MILLION)
- TABLE 7: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
- LIST OF FIGURES
- FIGURE 1: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2020 & 2028 (IN %)
- FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
- FIGURE 3: MARKET ATTRACTIVENESS INDEX
- FIGURE 4: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2021-2028 (IN $ MILLION)
- FIGURE 5: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2021-2028 (IN $ MILLION)
- FIGURE 6: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2021-2028 (IN $ MILLION)
- FIGURE 7: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2021-2028 (IN $ MILLION)
- FIGURE 8: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2021-2028 (IN $ MILLION)
- FIGURE 9: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2021-2028 (IN $ MILLION)
- FIGURE 10: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2021-2028 (IN $ MILLION)
- FIGURE 11: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2021-2028 (IN $ MILLION)
- FIGURE 12: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)
- FIGURE 13: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2021-2028 (IN $ MILLION)
- FIGURE 14: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2021-2028 (IN $ MILLION)
- FIGURE 15: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
- FIGURE 16: UNITED ARAB EMIRATES CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
- FIGURE 17: TURKEY CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
- FIGURE 18: SAUDI ARABIA CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
- FIGURE 19: SOUTH AFRICA CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
- FIGURE 20: REST OF MIDDLE EAST & AFRICA CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)